FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311254139> ?p ?o ?g. }

• W4311254139 endingPage "524" @default.
• W4311254139 startingPage "515" @default.
• W4311254139 abstract "Stereotactic body radiotherapy (SBRT) concepts for dose escalation are increasingly used for bone metastases in patients with oligometastatic or oligoprogressive disease. For metastases that are not suitable for SBRT-regimens, a treatment with 30/40 Gy with simultaneous integrated boost (SIB) in 10 fractions represents a possible regimen. The aim of this study was to investigate the feasibility of this concept and the acute and subacute toxicities.Clinical records for dose-escalated radiotherapy of all consecutive patients treated with this regimen were evaluated retrospectively (24 patients with 28 target volumes for oncologic outcomes and 25 patients with 29 target volumes for treatment feasibility and dose parameters analysis). Analysis of radiotherapy plans included size of target volumes and dosimetric parameter for target volumes and organs at risk (OAR). Acute and subacute toxicities were evaluated according to Common Terminology Criteria for Adverse Events (CTCAE) V4.0.The most common localization was the spine (71.4%). The most common histology was prostate cancer (45.8%). Oligometastatic or oligoprogressive disease was the indication for dose-escalated radiotherapy in 19/24 patients (79.2%). Treatment was feasible with all patients completing radiotherapy. Acute toxicity grade 1 was documented in 36.0% of the patients. During follow up, one patient underwent surgery due to bone instability. The 1-year local control and patient-related progression-free survival (PFS) were 90.0 ± 6.7% and 33.3 ± 11.6%, respectively.Dose-escalated hypofractionated radiotherapy with simultaneous integrated boost for bone metastases resulted in good local control with limited acute toxicities. Only one patient required surgical intervention. The regimen represents an alternative to SBRT in selected patients." @default.
• W4311254139 created "2022-12-25" @default.
• W4311254139 creator A5002463670 @default.
• W4311254139 creator A5012149069 @default.
• W4311254139 creator A5013235891 @default.
• W4311254139 creator A5033094522 @default.
• W4311254139 creator A5040615086 @default.
• W4311254139 creator A5056410467 @default.
• W4311254139 creator A5065356310 @default.
• W4311254139 creator A5087929700 @default.
• W4311254139 creator A5088830118 @default.
• W4311254139 creator A5089969952 @default.
• W4311254139 date "2022-12-01" @default.
• W4311254139 modified "2023-09-30" @default.
• W4311254139 title "Dose-escalated radiotherapy with simultaneous integrated boost for bone metastases in selected patients with assumed favourable prognosis" @default.
• W4311254139 cites W2002039079 @default.
• W4311254139 cites W2005521646 @default.
• W4311254139 cites W2014367320 @default.
• W4311254139 cites W2019582591 @default.
• W4311254139 cites W2029195555 @default.
• W4311254139 cites W207419586 @default.
• W4311254139 cites W2099101682 @default.
• W4311254139 cites W2103698695 @default.
• W4311254139 cites W2107890915 @default.
• W4311254139 cites W2117832658 @default.
• W4311254139 cites W2142138307 @default.
• W4311254139 cites W2146878763 @default.
• W4311254139 cites W2148255833 @default.
• W4311254139 cites W2168329091 @default.
• W4311254139 cites W2479968209 @default.
• W4311254139 cites W2529888262 @default.
• W4311254139 cites W2581677089 @default.
• W4311254139 cites W2775321189 @default.
• W4311254139 cites W2794734608 @default.
• W4311254139 cites W2899126550 @default.
• W4311254139 cites W2903376111 @default.
• W4311254139 cites W2903726898 @default.
• W4311254139 cites W2909905361 @default.
• W4311254139 cites W2945592235 @default.
• W4311254139 cites W2996951767 @default.
• W4311254139 cites W2999514732 @default.
• W4311254139 cites W3039778549 @default.
• W4311254139 cites W3119648854 @default.
• W4311254139 cites W3132720097 @default.
• W4311254139 cites W3135755751 @default.
• W4311254139 cites W3215094196 @default.
• W4311254139 cites W4240340450 @default.
• W4311254139 doi "https://doi.org/10.2478/raon-2022-0053" @default.
• W4311254139 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36503710" @default.
• W4311254139 hasPublicationYear "2022" @default.
• W4311254139 type Work @default.
• W4311254139 citedByCount "0" @default.
• W4311254139 crossrefType "journal-article" @default.
• W4311254139 hasAuthorship W4311254139A5002463670 @default.
• W4311254139 hasAuthorship W4311254139A5012149069 @default.
• W4311254139 hasAuthorship W4311254139A5013235891 @default.
• W4311254139 hasAuthorship W4311254139A5033094522 @default.
• W4311254139 hasAuthorship W4311254139A5040615086 @default.
• W4311254139 hasAuthorship W4311254139A5056410467 @default.
• W4311254139 hasAuthorship W4311254139A5065356310 @default.
• W4311254139 hasAuthorship W4311254139A5087929700 @default.
• W4311254139 hasAuthorship W4311254139A5088830118 @default.
• W4311254139 hasAuthorship W4311254139A5089969952 @default.
• W4311254139 hasBestOaLocation W43112541391 @default.
• W4311254139 hasConcept C121608353 @default.
• W4311254139 hasConcept C126322002 @default.
• W4311254139 hasConcept C126838900 @default.
• W4311254139 hasConcept C141071460 @default.
• W4311254139 hasConcept C143998085 @default.
• W4311254139 hasConcept C155806632 @default.
• W4311254139 hasConcept C197934379 @default.
• W4311254139 hasConcept C2777793932 @default.
• W4311254139 hasConcept C2780192828 @default.
• W4311254139 hasConcept C2781413609 @default.
• W4311254139 hasConcept C509974204 @default.
• W4311254139 hasConcept C71924100 @default.
• W4311254139 hasConceptScore W4311254139C121608353 @default.
• W4311254139 hasConceptScore W4311254139C126322002 @default.
• W4311254139 hasConceptScore W4311254139C126838900 @default.
• W4311254139 hasConceptScore W4311254139C141071460 @default.
• W4311254139 hasConceptScore W4311254139C143998085 @default.
• W4311254139 hasConceptScore W4311254139C155806632 @default.
• W4311254139 hasConceptScore W4311254139C197934379 @default.
• W4311254139 hasConceptScore W4311254139C2777793932 @default.
• W4311254139 hasConceptScore W4311254139C2780192828 @default.
• W4311254139 hasConceptScore W4311254139C2781413609 @default.
• W4311254139 hasConceptScore W4311254139C509974204 @default.
• W4311254139 hasConceptScore W4311254139C71924100 @default.
• W4311254139 hasIssue "4" @default.
• W4311254139 hasLocation W43112541391 @default.
• W4311254139 hasLocation W43112541392 @default.
• W4311254139 hasLocation W43112541393 @default.
• W4311254139 hasOpenAccess W4311254139 @default.
• W4311254139 hasPrimaryLocation W43112541391 @default.
• W4311254139 hasRelatedWork W1694442327 @default.
• W4311254139 hasRelatedWork W2047967234 @default.
• W4311254139 hasRelatedWork W2439875401 @default.
• W4311254139 hasRelatedWork W2791757935 @default.

• next